[Recent advances in cerebrovascular diseases from the view point of blood coagulation/fibrinolysis]

Ikuro Maruyama1

  • 1Department of Laboratory and Molecular Medicine, Kagoshima University Graduate School of Medicine and Dental Science.

Insights

Cerebrovascular diseases in Japan are linked to unique brain hemostasis. Decreased anticoagulant protein and increased tissue factor promote thrombosis, impacting stroke prevention and treatment.

Area of Science:

  • Neuroscience
  • Hematology
  • Vascular Biology

Context:

  • Cerebrovascular diseases (CVD) represent a significant clinical challenge in Japan.
  • Understanding the brain's unique hemostatic system is crucial for managing CVD.
  • This review focuses on the roles of blood coagulation, fibrinolysis, and platelets in brain circulation.

Purpose:

  • To review the patho-mechanisms underlying cerebrovascular diseases.
  • To explore prevention and treatment strategies for CVD.
  • To highlight the specific characteristics of the hemostatic system in the brain.

Summary:

  • The brain exhibits unique hemostatic properties, including decreased expression of thrombomodulin, an anticoagulant endothelial protein.
  • This reduction in thrombomodulin may lead to an increased thrombotic tendency in the brain compared to other organs.
  • The brain is also rich in tissue factor, which can activate the extrinsic coagulation pathway upon vascular injury, with thrombin regulation being less efficient due to low thrombomodulin.

Impact:

  • Provides insights into the specific molecular mechanisms driving cerebrovascular diseases.
  • Informs the development of targeted prevention and treatment strategies for stroke and other CVDs.
  • Highlights the importance of considering organ-specific hemostatic differences in clinical practice.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...